International Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology 1989-01-01

Thin layer chromatographic detection of kryptofix 2.2.2 in the routine synthesis of [18F]2-fluoro-2-deoxy-D-glucose.

T Chaly, J R Dahl

Index: Int. J. Rad. Appl. Instrum. B 16(4) , 385-7, (1989)

Full Text: HTML

Abstract

A simple procedure for the detection of 4,7,13,16,21,24-hexaoxa-1,10-diazabicyclo (8.8.8) hexacosane (Kryptofix 2.2.2) in the final solution of [18F]FDG prepared by the aminopolyether supported nucleophilic substitution of 1,3,4,6-tetra-O-acetyl 2-O-trifluoromethanesulfonyl-beta-D-mannopyranose (Hamacher et al., 1986) has been developed. Presence of Kryptofix 2.2.2 in the routine production of [18F]FDG was detected using methanol/ammonium hydroxide (9:1) solvent system. A method to remove Kryptofix from [18F]FDG solution has been suggested.

Related Compounds

  • 2,2,2-Cryptand

Related Articles:

Rapid synthesis of a 5'-fluorinated oligodeoxy-nucleotide: a model antisense probe for use in imaging with positron emission tomography (PET).

1998-06-02

[Bioorg. Med. Chem. Lett. 8(11) , 1317-20, (1998)]

Simultaneous analysis of FDG, ClDG and Kryptofix 2.2.2 in [18F]FDG preparation by high-performance liquid chromatography with UV detection.

2008-02-01

[Nucl. Med. Biol. 35(2) , 239-44, (2008)]

Transport of alkali cations through thin lipid membranes by (222)C10-cryptand, an ionizable mobile carrier.

1986-01-01

[J. Membr. Biol. 89(3) , 251-67, (1986)]

Cation radius effects on the helix-coil transition of DNA. Cryptates and other large cations.

1990-04-01

[Biophys. J. 57(4) , 829-34, (1990)]

Determination of residual Kryptofix 2.2.2 levels in [18F]-labeled radiopharmaceuticals for human use.

2007-12-01

[Appl. Radiat. Isot. 65(12) , 1359-62, (2007)]

More Articles...